Longitudinal PFS Data From SEQUOIA: Implications For CLL Frontline Therapy Decisions
Advances in chronic lymphocytic leukemia (CLL) research continue to refine frontline treatment strategies, particularly as longer follow-up data become available from pivotal phase 3 trials. […]